Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Indreshpal Kaur

Showing results (11-20 of 22) with videos related to

Pageof 3
Sort By:
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|May 17, 2017
Ex Vivo Mesenchymal Precursor Cell-Expanded Cord Blood Transplantation after Reduced-Intensity Conditioning Regimens Improves Time to Neutrophil RecoveryRohtesh S Mehta, Rima M Saliba, Kai Cao, et al.
Transplantation and Cellular Therapy|October 27, 2023
Generation of Non-Alloreactive Antiviral Central Memory CD8 Human Veto T Cells for Cell TherapyEsther Bachar-Lustig, Assaf Lask, Yaki Eidelstein, et al.
Plos One|November 9, 2013
Antigen presenting cell-mediated expansion of human umbilical cord blood yields log-scale expansion of natural killer cells with anti-myeloma activityNina Shah, Beatriz Martin-Antonio, Hong Yang, et al.
British Journal of Haematology|March 16, 2017
Phase I study of cord blood-derived natural killer cells combined with autologous stem cell transplantation in multiple myelomaNina Shah, Li Li, Jessica McCarty, et al.
Frontiers in Immunology|March 15, 2021
GMP-Compliant Universal Antigen Presenting Cells (uAPC) Promote the Metabolic Fitness and Antitumor Activity of Armored Cord Blood CAR-NK CellsEnli Liu, Sonny O T Ang, Lucila Kerbauy, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|July 5, 2026
Treatment of Progressive Multifocal Leukoencephalopathy with Third-Party Allogeneic BK Virus T CellsAmanda Olson, Ye Li, David Marin, et al.
Biorxiv : the Preprint Server for Biology|September 30, 2020
Generation of glucocorticoid resistant SARS-CoV-2 T-cells for adoptive cell therapyRafet Basar, Nadima Uprety, Emily Ensley, et al.
The New England Journal of Medicine|December 14, 2012
Cord-blood engraftment with ex vivo mesenchymal-cell cocultureMarcos de Lima, Ian McNiece, Simon N Robinson, et al.
Nature Medicine|April 4, 2025
Allogeneic NK cells with a bispecific innate cell engager in refractory relapsed lymphoma: a phase 1 trialYago Nieto, Pinaki Banerjee, Indreshpal Kaur, et al.
Cell Reports|July 16, 2021
Generation of glucocorticoid-resistant SARS-CoV-2 T cells for adoptive cell therapyRafet Basar, Nadima Uprety, Emily Ensley, et al.
Pageof 3

Showing results (11-20 of 22) with videos related to

Sort By:
Pageof 3
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|May 17, 2017
Ex Vivo Mesenchymal Precursor Cell-Expanded Cord Blood Transplantation after Reduced-Intensity Conditioning Regimens Improves Time to Neutrophil RecoveryRohtesh S Mehta, Rima M Saliba, Kai Cao, et al.
Transplantation and Cellular Therapy|October 27, 2023
Generation of Non-Alloreactive Antiviral Central Memory CD8 Human Veto T Cells for Cell TherapyEsther Bachar-Lustig, Assaf Lask, Yaki Eidelstein, et al.
Plos One|November 9, 2013
Antigen presenting cell-mediated expansion of human umbilical cord blood yields log-scale expansion of natural killer cells with anti-myeloma activityNina Shah, Beatriz Martin-Antonio, Hong Yang, et al.
British Journal of Haematology|March 16, 2017
Phase I study of cord blood-derived natural killer cells combined with autologous stem cell transplantation in multiple myelomaNina Shah, Li Li, Jessica McCarty, et al.
Frontiers in Immunology|March 15, 2021
GMP-Compliant Universal Antigen Presenting Cells (uAPC) Promote the Metabolic Fitness and Antitumor Activity of Armored Cord Blood CAR-NK CellsEnli Liu, Sonny O T Ang, Lucila Kerbauy, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|July 5, 2026
Treatment of Progressive Multifocal Leukoencephalopathy with Third-Party Allogeneic BK Virus T CellsAmanda Olson, Ye Li, David Marin, et al.
Biorxiv : the Preprint Server for Biology|September 30, 2020
Generation of glucocorticoid resistant SARS-CoV-2 T-cells for adoptive cell therapyRafet Basar, Nadima Uprety, Emily Ensley, et al.
The New England Journal of Medicine|December 14, 2012
Cord-blood engraftment with ex vivo mesenchymal-cell cocultureMarcos de Lima, Ian McNiece, Simon N Robinson, et al.
Nature Medicine|April 4, 2025
Allogeneic NK cells with a bispecific innate cell engager in refractory relapsed lymphoma: a phase 1 trialYago Nieto, Pinaki Banerjee, Indreshpal Kaur, et al.
Cell Reports|July 16, 2021
Generation of glucocorticoid-resistant SARS-CoV-2 T cells for adoptive cell therapyRafet Basar, Nadima Uprety, Emily Ensley, et al.
Pageof 3